Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Emergent Health Corp.
Emergent Announces New Wholistic Re-Branding of all Products
July 28, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent's Pending Acquisition "Evolutionary Biologics" Engages "Aesthetics By Design" to Market, Sell and Distribute Regenerative Medicine Products Produced by Evolutionary Biologics with the Initial Focus Being Exo Elixir(TM)
July 26, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Closing in on Acquisition of Regen Biowellness Regens Bankruptcy Motion to Dismiss Approved Former L'Oréal President Jim Morrison Set to Join Emergents Board of Directors
July 21, 2022
From
Emergent Health Corp.
Via
AccessWire
Topics
Bankruptcy
Exposures
Financial
Legal
Tickers
EMGE
Emergent Executes Letter of Intent To Acquire Evolutionary Biologics; Former L'Oréal President Jim Morrison To Become Full Time CEO of Emergent
July 19, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent and Proposed Acquisition Partner Regen Biowellness to Re-Launch FDA Registered Patented Immune Booster ImmunaZin(TM) To Significantly Increase Revenues
July 12, 2022
From
Emergent Health Corp.
Via
AccessWire
Exposures
Product Safety
Tickers
EMGE
Emergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate Update
July 08, 2022
From
Emergent Health Corp.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
EMGE
Emergent executes Letter of Intent with Regen Biowellness, Inc.; Former L'Oréal President Jim Morrison to join Emergents Management Team
July 06, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Health Executes Binding Letter of Intent to Acquire Fusion Specialty Pharmacy
June 29, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Health Subsidiary PharmaZu Executes Agreement with DynaCord to Develop Various Injectable and Topical Biologic Exosomes for the Treatment of Arthritis, Joint Care, Wound Care, and Inflammation for Pets
March 02, 2022
From
Emergent Health Corp.
Via
AccessWire
Exposures
COVID-19
Tickers
EMGE
Emergent Health's Chief Marketing Officer Marvin Segel, Son of QVC Founder Joseph Segel to Appear Today on the Digital Stock & Investment News Network Rich TV Live at 1:00 PM ET
February 21, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Health Appoints Marvin Segel, Son of QVC Founder Joseph Segel as Director and Chief Marketing Officer
February 15, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Health Appoints Former Vice-President and Director of Enzolytics, James Zimbler as Chief Executive Officer
February 09, 2022
From
Emergent Health Corp.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
EMGE
EMGE Announces Death of President and Founder Dr. John V. Cappello
February 08, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Health to Enter the Projected $60 Billion Global Anti-Aging Market
February 03, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Emergent Health Acquires PharmaZu Corp. to Enter the $30 Billion Global Veterinary Medicine Market
February 01, 2022
From
Emergent Health Corp.
Via
AccessWire
Tickers
EMGE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.